http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-PI0401888-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bb66d9373d09efad73c142762f6dfb00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4184 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28 |
filingDate | 2004-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2730b36127aaa67f769c57be64885dc |
publicationDate | 2006-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | BR-PI0401888-A |
titleOfInvention | Oral application form for 3 - [(2 - {[4- (hexyloxycarbonylamino-imino-methyl) -phenylamino] -methyl} -1-methyl-1h-benzimidazol-5-carbonyl) -pyridin-2-acid ethyl esters il-amino] -propionic and its salts |
abstract | "ORAL FORM OF APPLICATION FOR 3- ¢ (2- {¢ 4- (HEXYLOXICARBONYLAMINE-IMMINETHYL) (PHENYLAMINE O! -METHYL) -1-METHYL-BENZIMIDAZOL-5-CARBONYL ACID ETHYLTERS" L-AMINO! -PROPYNIC AND ITS SALTS ". The present invention relates to a novel oral application form to be applied to the 3- ¢ (2- {¢ 4- (hexyloxycarbonylamino-imino-methyl) -phenylaminolmethyl} -1-methyl-1 H acid ethylester active substance -benzimidazol-5-carbonyl) -pyridin-2-yl-amino-propionic and pharmaceutically compatible salts thereof. |
priorityDate | 2004-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Predicate | Subject |
---|---|
isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6115 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419479687 |
Total number of triples: 13.